SCHEMBL13748646

SCHEMBL13748646

CC(C)(C)OC(=O)CNC(=O)OC1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.41
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RECQL P46063 1/20 0.35
KAT2B Q92831 1/20 0.34
BAZ2B Q9UIF8 1/20 0.34
HCRTR2 O43614 1/20 0.33
MLYCD O95822 1/20 0.33
EPHX2 P34913 1/20 0.33
CTSD P07339 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
GAA P10253 1/20 0.33
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2860088 0.79 EPHX1 (0.43) EPHX1ALDH1A1KAT2BBAZ2BCTSL
SCHEMBL8371398 0.77 EPHX1 (0.68) EPHX1ALDH1A1KMT2AMEN1KAT2B
SCHEMBL16114964 0.76 USP2 (0.38) EPHX1USP2SMN1; SMN2RECQLCTSD
SCHEMBL2159267 0.76 KMT2A (0.49) EPHX1ALDH1A1KMT2AMEN1TSHR
SCHEMBL23366889 0.74 KMT2A (0.45) EPHX1ALDH1A1KMT2AMEN1TSHR
SCHEMBL7821456 0.74 KAT2B (0.39) EPHX1SMN1; SMN2KAT2BBAZ2B
SCHEMBL12335551 0.73 EPHX1 (0.50) EPHX1ALDH1A1KMT2AMEN1TSHR
SCHEMBL24325888 0.73 KAT2B (0.37) EPHX1USP2SMN1; SMN2RECQLKAT2B
SCHEMBL1927025 0.73 AAK1 (0.35) EPHX1USP2SMN1; SMN2RECQLKAT2B
SCHEMBL125503 0.72 TDP1 (0.52) EPHX1ALDH1A1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009102325-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 WO disclosed
WO-2008021927-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO disclosed